REGENXBIO, Sarepta Settle Elevidys AAV Patent Disputes in Delaware

A Delaware federal court granted the parties' joint stipulations of dismissal on October 7, 2026, ending two patent cases over the Elevidys AAV gene therapy platform; settlement terms are not disclosed in the reporting.